- Home
- UTHR vs CMS Comparison
UTHR vs CMS Comparison
Compare UTHR & CMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- CMS
- Stock Information
- Founded
- UTHR 1996
- CMS 1987
- Country
- UTHR United States
- CMS United States
- Employees
- UTHR N/A
- CMS N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- CMS Power Generation
- Sector
- UTHR Health Care
- CMS Utilities
- Exchange
- UTHR Nasdaq
- CMS Nasdaq
- Market Cap
- UTHR 20.7B
- CMS 21.5B
- IPO Year
- UTHR 1999
- CMS N/A
- Fundamental
- Price
- UTHR $448.47
- CMS $73.24
- Analyst Decision
- UTHR Buy
- CMS Buy
- Analyst Count
- UTHR 15
- CMS 12
- Target Price
- UTHR $459.60
- CMS $76.82
- AVG Volume (30 Days)
- UTHR 846.4K
- CMS 2.5M
- Earning Date
- UTHR 10-29-2025
- CMS 10-30-2025
- Dividend Yield
- UTHR N/A
- CMS 2.96%
- EPS Growth
- UTHR 17.94
- CMS 3.96
- EPS
- UTHR 25.63
- CMS 3.39
- Revenue
- UTHR $3,077,800,000.00
- CMS $8,017,000,000.00
- Revenue This Year
- UTHR $13.71
- CMS $8.73
- Revenue Next Year
- UTHR $5.72
- CMS $3.99
- P/E Ratio
- UTHR $17.38
- CMS $21.62
- Revenue Growth
- UTHR 17.62
- CMS 8.25
- 52 Week Low
- UTHR $266.98
- CMS $63.97
- 52 Week High
- UTHR $459.48
- CMS $76.45
- Technical
- Relative Strength Index (RSI)
- UTHR 65.25
- CMS 56.93
- Support Level
- UTHR $415.00
- CMS $72.99
- Resistance Level
- UTHR $459.40
- CMS $74.56
- Average True Range (ATR)
- UTHR 13.47
- CMS 1.16
- MACD
- UTHR -1.34
- CMS 0.22
- Stochastic Oscillator
- UTHR 71.49
- CMS 68.50
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.